INHIBITION BY AMILORIDE OF EXPERIMENTAL CARCINOGENESIS INDUCED BY AZASERINE IN RAT PANCREAS

Citation
M. Tatsuta et al., INHIBITION BY AMILORIDE OF EXPERIMENTAL CARCINOGENESIS INDUCED BY AZASERINE IN RAT PANCREAS, Cancer letters, 106(1), 1996, pp. 23-28
Citations number
29
Categorie Soggetti
Oncology
Journal title
ISSN journal
03043835
Volume
106
Issue
1
Year of publication
1996
Pages
23 - 28
Database
ISI
SICI code
0304-3835(1996)106:1<23:IBAOEC>2.0.ZU;2-Y
Abstract
The effects of prolonged administration of the diuretic amiloride on p ancreatic carcinogenesis induced by azaserine and on the labeling inde x of carcinogen-induced pancreatic lesions were investigated in Wistar rats. Rats were given 25 weekly injections of 10 mg/kg body weight az aserine and also 5 mg/kg body weight amiloride every other day until t he end of the experiment at week 62. Carcinogen-induced pancreatic les ions were examined by histochemical techniques and were classified as ATPase-positive or ATPase-negative. In week 62, quantitative histologi c analysis showed that prolonged administration of amiloride significa ntly reduced the number and size (as percent of parenchyma) of ATPase- positive pancreatic lesions, which are closely correlated with the sub sequent development of pancreatic cancer. Amiloride also significantly decreased the labeling index of carcinogen-induced pancreatic lesions , but not of the surrounding acinar cells. In contrast, amiloride has no significant influence on the number and size of ATPase-negative pan creatic lesions. These findings indicate that amiloride inhibits pancr eatic carcinogenesis, and that this effect may be related to the reduc tion of ATPase-positive lesions and to amiloride's inhibition of cell proliferation in neoplastic lesions of the pancreas.